Pancreatic cancer is one of the deadliest cancers of all. A new mRNA vaccine could prevent tumors from returning after surgery. Nine out of ten people do
Data indicate that the pancreas as a target of SARS-CoV-2 infection and suggest that pancreatic beta cell involvement could contribute to the metabolic dysregulation seen in patients with COVID-19.
A study carried out by a team of researchers from Helmholtz Zentrum München, the Technical University of Munich (TUM) and Ulm University Medical Center, have engineered a new organoid on chip platform that provides urgently needed access to the first steps of human pancreatic duct formation. Click to read more.